Brain natriuretic peptide in the diagnosis of structural and functional changes of the myocardium in men with uncomplicated and asymptomatic hypertension with polymorphic variants of aldosteronesynthase gene


  • M. Lozinska National Pirogov Memorial Medical University, Vinnytsya, Ukraine
Keywords: aldosteronesynthase, genetic polymorphism, BNP, CYP11B2, aldosterone, RAAS, hypertension, left ventricular hypertrophy

Abstract

According to previous studies, aldosterone is responsible for myocardial remodeling and, ultimately, myocardial dysfunction. Aldosterone synthase gene (CYP11B2) as the main controller of aldosterone may be involved in the variability of renin-angiotensin-aldosterone system (RAAS) activity. Brain natriuretic peptide (BNP) is a marker for the diagnosis of chronic heart failure and it’s a contraregulatory peptide of RAAS. The aim of our study was to investigate the levels of BNP plasma concentrations in men with uncomplicated hypertension, carriers of polymorphic variants of the CYP11B2 gene. The study involved 150 men: 50 men of control group and 100 men of main group patients with hypertension of I-II stages. Each participant underwent office blood pressure measurement, echocardiography, determination of plasma levels of BNP in serum by immunoassay (ELISA) and determination of C-344T polymorphism of CYP11B2 gene in venous blood samples by PCR. Mathematical processing of obtained data was performed using standard statistical package STATISTICA 10.0. In accordance with the normal distribution, obtained results were presented as mean and standard deviation. In case of discrepancy of normal distribution a median of 25-75% of quartiles, including half of all parameter values, was given. For comparing groups by investigated parameters, the Student's t test was used for normal distribution, and in the absence of normal distribution, its non-parametric analogs were used: the Mann-Whitney or ANOVA test. It was found that male carriers of CC polymorphism of CYP11B2 gene had higher plasma concentrations of BNP and in the group of patients with essential hypertension and left ventricle hypertrophy (LVH) the representatives of this polymorphic variant of CYP11B2 gene had more severe diastolic disorders and signs of myocardial remodeling. The TT carrier of the CYP11B2 gene polymorphism was associated with excess body mass and lower BNP levels.

References

1. Hefter, Yu. O., & Zhebel, V. M. (2006). Stan miokardu u khvorykh na hipertonichnu khvorobu v zalezhnosti vid variantu henotypu retseptoru anhiotenzynu II 1-ho typu ta naiavnosti sudynnykh uskladnen [Myocardial status in patients with hypertension depending on the variant genotype of the angiotensin II type 1 receptor and the presence of vascular complications]. Halytskyi likarskyi visnyk – Galician Medical Bulletin, 13 (1), 20–24.

2. Dolzhenko, M. M., Dosenko, V. Ye., & Lobach, L. Ye. (2017). Polimorfizm hena aldosteron syntetazy (CYP11b2) ta strukturni pokaznyky livoho shlunochka v patsiientiv z IKhS, postinfarktnym kardiosklerozom [Aldosterone synthetase gene (CYP11b2) polymorphism and left ventricular structural indices in patients with coronary heart disease, postinfarction cardiosclerosis]. Zaporizkyi medychnyi zhurnal – Zaporizhzhya Medical Journal, 6 (105), 716–725. Vziato z http://nbuv.gov.ua/UJRN/Zmzh_2017_19_6_7.

3. Palii, I. K., Zhebel, V. M., Sakovych, O. O., & Humeniuk, A. F. (2015). Plazmovi rivni mozkovoho natriiuretychnoho peptydu u zhinok postmenopauznoho viku z hipertonichnoiu khvoroboiu, neuskladnenoiu ta uskladnenoiu khronichnoiu sertsevoiu nedostatnistiu [Plasma levels of brain natriuretic peptide in postmenopausal women with hypertension, uncomplicated and complicated chronic heart failure]. Ukrainskyi kardiolohichnyi zhurnal. Materialy XVI natsionalnoho konhresu kardiolohiv Ukrainy. Kyiv, 23–25 veresnia 2015 – Ukrainian Cardiology Journal. Proceedings of the 16th National Congress of Cardiologists of Ukraine. Kyiv, September 23–25, 2015.

4. Yahontov, D. A., Derisheva, D. A., & Gulyaeva, L. F. (2014). Polimorfizm gena aldosteronsintazy u bolnyh arterialnoj gipertenziej v sochetanii s ishemicheskoj boleznyu serdca pri razlichnoj masse miokarda levogo zheludochka [Polymorphism of the aldosterone synthase gene in patients with arterial hypertension in combination with coronary heart disease with different masses of the left ventricular myocardium]. Sistemnye gipertenzii – Systemic hypertension, 11 (1), 16–20. DOI:10.26442/2075-082X_11.1.16-20.

5. Almeida, P., Azevedo, A., Rodrigues, R., Dias, P., Friões, F., Vazquez, B., … Barros, H. (2003). B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients. Rev. Port. Cardiol., 22 (3), 327–36. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/12847875.

6. Borges, V.T.M., Zanati, S. G., Peraçoli, M.T.S., Poiati, J.R., Romão-Veiga, M., Peraçoli, J. C., & Thilaganathan, B. (2018). Maternal left ventricular hypertrophy and diastolic dysfunction and brain natriuretic peptide concentration in early- and late-onset pre-eclampsia. Ultrasound Obstet Gynecol., 51 (4), 519–523. doi: 10.1002/uog.17495.

7. Grewal, J., McKelvie, R., Lonn, E., Tait, P., Carlsson, J., Gianni, M., & Persson, H. (2008). BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. European Journal of Heart Failure, 10 (3), 252–259. doi:10.1016/j.ejheart.2008.01.017.

8. Hlubocká, Z., Jáchymová, M., Heller, S., Umnerová, V., Danzig, V., & Lánská, V. (2009). Association of the -344T/C aldosterone synthase gene variant with essential hypertension. Pysiological Research., 58 (6), 785–92.

9. Kupari, M., Hautanen, A., Lankinen, L., Koskinen, P., Virolainen, J., Nikkila, H., & White, P. (1998). Associations Between Human Aldosterone Synthase (CYP11B2) Gene Polymorphisms and Left Ventricular Size, Mass, and Function. Circulation, 97 (6), 569–75. DOI:10.1161/01.cir.97.6.569.

10. Ledwidge, M., Gallagher, J., Conlon, C., Tallon, E., O’Connell, E., Dawkins, I., … McDonald, K. (2013). Natriuretic Peptide–Based Screening and Collaborative Care for Heart Failure. JAMA, 310 (1), 66–74. doi:10.1001/jama.2013.7588.

11. Lukowicz, T., Fischer, M., Hense, H. W., Döring, A., Stritzke, J., Riegger, G., … Luchner, A. (2005). BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy. European Journal of Heart Failure, 7 (4), 525–531. doi:10.1016/j.ejheart.2004.12.010.

12. Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., … Waggoner, A. D. (2016). ASE/EACVI GUIDELINES AND STANDARDS. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr., 29 (4), 277–314. doi: 10.1016/j.echo.2016.01.011.

13. Pashkova, I., Zhebel, V. M., Palahniuk, H. O., Sakovych, O. O., Starzhynska, O. L., … Gumenyuk, A. F. (2015). The BNP gene polymorphism as a regulator of brain natriuretic peptide plasma level in men with uncomplicated essential hypertension and left ventricular hypertrophy. Biological markers and guided therapy, 2 (1), 13–23. Retrieved from https://www.researchgate.net/publication/299388828_The_BNP_Gene_Polymorphism_as_a_Regulator_of_Brain_Natriuretic_Peptide_Plasma_Level_in_Men_with_Uncomplicated_Essential_Hypertension_and_Left_Ventricular_Hypertrophy.

14. Sookoian, S., Gianotti, T., & Pirola, C. (2009). Role of the C-344T aldosterone synthase gene variant in left ventricular mass and left ventricular structure-related phenotypes. Electrolyte Blood Press, 7 (2), 67–72. DOI: 10.1136/hrt.2007.119545.

15. Wang, L., Zhou, J., Zhang, B., Wang, H., Li, M., Niu, Q., Chen, Y., & Chen, R., Wen, S. (2015). Association of echocardiographic left ventricular structure and −344C/T aldosterone synthase gene variant: A meta-analysis. Journal of the Renin-Angiotensin Aldosterone System, 16 (4), 858–871. https://doi.org/10.1177/1470320314535459.

16. Wong, P. C., Guo, J., & Zhang. A. (2017). The renal and cardiovascular effects of natriuretic peptides. Adv. Physiol. Educ., 41 (2), 179–185. doi: 10.1152/advan.00177.2016.

17. Xanthakis, V., Larson, M. G., Wollert, K. C., Aragam, J., Cheng, S., Ho, J., … Vasan, R. S. (2013). Association of Novel Biomarkers of Cardiovascular Stress With Left Ventricular Hypertrophy and Dysfunction: Implications for Screening. Journal of the American Heart Association, 2 (6), e000399–e000399. doi:10.1161/jaha.113.000399.

18. Yin, C., Gu, W., Gao, Y., Li, Z., Chen, X., Li, Z., Chen, X., Li, Zh. & Wen, Sh. (2017). Association of the -344T/C polymorphism in aldosterone synthase gene promoter with left ventricular structure in Chinese Han: A meta-analysis. Clin. Exp. Hypertens., 39 (6), 562–569. doi: 10.1080/10641963.2017.1291660.
Published
2019-09-02
How to Cite
Lozinska, M. (2019). Brain natriuretic peptide in the diagnosis of structural and functional changes of the myocardium in men with uncomplicated and asymptomatic hypertension with polymorphic variants of aldosteronesynthase gene. Reports of Vinnytsia National Medical University, 23(3), 448-454. https://doi.org/https://doi.org/10.31393/reports-vnmedical-2019-23(3)-18